- Supported exchanges /
- SHG /
- 688193.SHG
Shanghai Rendu Biotechnology Co. Ltd. A (688193 SHG) stock market data APIs
¥38.8
-0.9(-2.3%)
as of December 20, 2024
Price chart is built with Anychart
Shanghai Rendu Biotechnology Co., Ltd. engages in the development and promotion of RNA molecular diagnostic technology and products. The company offers products in the areas of reproductive health, respiratory diseases, enterovirus, food safety, and blood infectious diseases, as well as automatic nucleic acid detection and analysis system. The company was founded in 2007 and is based in Shanghai, China.
Shanghai Rendu Biotechnology Co. Ltd. A Financial Data Overview
39.7 | |
38.8 | |
- | |
39.81 | |
38.51 | |
22.2706-50.3 | |
1 588 M | |
73.5185 | |
40 000 K | |
178 M | |
-0.095 | |
0.0076 | |
0.226 |
Our easy-to-use no-coding solutions help you get the data effortlessly:
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
General: {
Code:
'688193',
Type:
'Common Stock',
Name:
'Shanghai Rendu Biotechnology Co. Ltd. A',
Exchange:
'SHG',
CurrencyCode:
'CNY',
CurrencyName:
'Renminbi',
CurrencySymbol:
'¥',
CountryName:
'China',
CountryISO:
'CN',
OpenFigi:
NULL,
ISIN:
'CNE1000059K5',
CIK:
NULL,
EmployerIdNumber:
NULL,
FiscalYearEnd:
'December',
IPODate:
NULL,
InternationalDomestic:
NULL,
Sector:
'Healthcare',
Industry:
'Diagnostics & Research',
}
Shanghai Rendu Biotechnology Co. Ltd. A Fundamental Data is available in our Financial Data APIs
- Net Revenue 178 M
- EBITDA 2 870 K
- Earnings Per Share 0.54
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get Shanghai Rendu Biotechnology Co. Ltd. A Earnings via APIs
- Latest Release 2023-06-30
- EPS/Forecast NaN
Get Shanghai Rendu Biotechnology Co. Ltd. A End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Do you have any questions?
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also: